Cardio Diagnostics Holdings Inc. [CDIO] Revenue Reported at $0.00 Million, Down -74.85% YTD: What’s Next?


Cardio Diagnostics Holdings Inc. [NASDAQ: CDIO] The trading session closed at $2.47 on 11/21/22. The stock reached a low of $1.85 in the day’s price range, while the highest price level was $2.84. The Company reports on November 21, 2022 that Cardio Diagnostics Benchmarks will present the Company’s upcoming discoveries in a one-on-one investor conference call.


China Can’t Stop US$0.25 Of Stock From Mining The Ultra-Rare Metal

Here’s a tiny company—trading at an unheard-of below 25-cents per share—that is developing one of the largest and highest-quality REE deposits in all of North America…and the Chinese are all about it. Can’t do anything! It’s early stages… and that’s great news for individual investors like you who have the foresight to act decisively on an emerging megatrend that is already being measured in the tens of billions of dollars.

Just click here and the name and trading symbol is yours.

sponsored


Cardio Diagnostics Holdings Inc. (Nasdaq: CDIO) today announced that it will present at The Benchmark Company’s 11th Annual Discovery One-on-One Investor Conference, to be held on Thursday, December 1, 2022 at the New York Athletic Club in New York City Will.

Misha Dogan, PhD, Cardio Diagnostics CEO, co-founder and board member, is scheduled to participate in one-on-one meetings with institutional analysts and investors throughout the day.

Year-to-date performance of the shares is -74.85 percent and weekly performance is 18.18 percent. The stock has performed -69.12 percent in recent 30 days and -75.14 percent in last 3 months.

If compared with the average trading volume of 112.85K shares, CDIO reached a volume of 5722520 in the most recent trading day, which is why market watchdogs consider the stock active.

Here’s what the leading stock market gurus have to say about Cardio Diagnostics Holdings Inc. [CDIO],

Based on careful and fact-backed analyzes by Wall Street experts, the current consensus on a target price for CDIO shares is $8.00 per share. Target prices and analysis on the performance of stocks are usually carefully studied by market experts, and the current Wall Street consensus on CDIO stock is a recommendation at 2.00. This rating represents a strong buy recommendation on a scale of 1 to 5, where 5 means strong sell, 4 represents sell, 3 indicates hold and 2 indicates buy.

Cardio Diagnostics Holdings Inc. The Average True Range (ATR) for CDIO stock is set at 0.58, with the Price to Sales ratio for CDIO stock at 26947.95 over the trailing 12 months period. The Price to Book ratio for the previous quarter was 0.31, the Price to Cash per Share for the corresponding quarter was set at 0.02.

cdio stock trading performance evaluation

Cardio Diagnostics Holdings Inc. [CDIO] Got into the green zone at the end of last week, in a positive trend and rising up to 18.18.

Overbought and oversold stocks can be easily detected with the Relative Strength Index (RSI), where an RSI result of over 70 will result in overbought, and any rate below 30 will indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CDIO stock for the past two-week period is set at 29.45, the RSI for the last single at 41.86, and the three-week RSI for Cardio Diagnostics Holdings Inc. is set at 24.01. [CDIO], The current moving average for the last 50 days of trading of this stock is 6.8800, while it was recorded at 1.9700 for the last one week of trading.

Cardio Diagnostics Holdings Inc. [CDIO]: An Insightful Look at the Fundamentals

Equally intriguing is the liquidity data of Cardio Diagnostics Holdings Inc., which has a quick ratio of 0.40 and a current ratio set at 0.40.

Cardio Diagnostics Holdings Inc. [CDIO]: Insider Ownership Position

Institutional investors currently hold approximately $13 million, or 55.60%, of CDIO stock in their hands. The top three institutional holders of CDIO stock are: Periscope Capital Inc. with ownership of 557,337, which accounts for approximately 0% of the company’s market cap and approximately 19.80% of total institutional ownership; Sabah Capital Management, LP, holds 471,299 shares of CDIO stock with an estimated value of $1.16 million in shares of stock; and KARPUS MANAGEMENT, INC., currently owning approximately -0.033% of the company’s market capitalization with $1.13M in CDIO stock.

Cardio Diagnostics Holdings Inc. IN stock positions of institutional investors increased at the end of November and during the November reporting period, where 4 institutional holders held Cardio Diagnostics Holdings Inc. I increased my position. [NASDAQ:CDIO] By approximately 419,581 shares. Additionally, 7 investors reduced positions by approximately 756,626 shares, while 27 investors maintained positions amounting to 4,044,082 shares. As per the latest SEC report filing, the mentioned changes put the institutional holdings at 5,220,289 shares. There were 3 new institutional investments in CDIO stock for a total of 416,776 shares, while 3 institutional investors sold 668,572 shares during the same period.

Leave a Comment

Your email address will not be published.

Then We Knew It Was on..” – Roman Reigns Shark Tank Keto Gummies Scam Alert? McDonald’s Halloween Buckets Could Be Back How to Watch Spacecraft Collide With Deep Space Asteroid Grand Theft Auto VI footage leaked after the hack Floyd Mayweather Jr boxer knocks out Mikuru Asakura martial artist